TrialAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2016

C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

Finnian R Mc Causland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.